OREANDA-NEWS  The European Medicines Agency announced that it has not gotten a request for recording of the Russian vaccine "Sputnik V". This information is reported in a press release on the agency's website.

The publication says that at the moment EMA has not gotten an implementation for approval of the "Sputnik V" vaccine, which was designed by the National Research Center for Epidemiology and Microbiology in Russia.

EMA also said that they had provided an opportunity to apply, and the Russian Direct Investment Fund said that the implementation had already been submitted.

On February 2, the medical journal The Lancet informed the results of the third phase of clinical trials of the Russian vaccine shows 91.6 percent effectiveness against coronavirus. 19,866 people took part in testing the vaccine.